Chair: Greta Wilkening, University of Colorado, School of Medicine, Colorado Children’s Hospital
Discussant: Tracy King, NIH/NICHD
Papers:
- What to do when our Tests Fail us? Cognitive Testing in Rare Genetic Conditions: Audrey Thurm, Neurodevelopmental and Behavioral Phenotyping Service, NIMH Intramural Research Program; Cristan Farmer, Neurodevelopmental and Behavioral Phenotyping Service, NIMH Intramural Research Program
- Development and validation of a suite of outcome measures for CDKL5 Deficiency Disorder : Scott Demarest, University of Colorado, School of Medicine, Precision Medicine, Children’s Hospital Colorado
- Use of objective motor measures and developmental assessment to assess clinically meaningful change in Angelman syndrome trials: Jessica Duis, University of Colorado, School of Medicine, Children’s Hospital Colorado
- Target Engagement Using EEG Biomarkers in Fragile X Syndrome: A Case Example : Lauren Schmitt, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine
- Using Innovative Methods to Assess Cognition and Behavior in Individuals with Intellectual and Developmental Disabilities: Andrew Dakopolos, UC Davis Mind Institute, Translational Psychophysiology and Assessment Laboratory; Emma Condy, National Institute of Health; Elizabeth Smith, Cincinnati Children’s Hospital Medical Center; Dana Glassman, MIND Institute, UC Davis; Danielle Harvey, UC Davis, Aaron Kaat, Richard Gershon, Claire Michalak, Jeanine Coleman, Keith Widaman, Karen Riley, Elizabeth Berry-Kravitz and David Hessl